Burning Rock Biotech Ltd. (BNR)
16.30
+0.17
(+1.05%)
USD |
NASDAQ |
Apr 01, 16:00
17.02
+0.72
(+4.42%)
Pre-Market: 09:23
Burning Rock Biotech EPS Diluted (Quarterly) : -0.2071 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6781 |
| Zai Lab Ltd. | -0.4578 |
| WuXi Biologics (Cayman), Inc. | -- |
| Viva Biotech Holdings | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.17M |
| Revenue (Quarterly) | 17.81M |
| Total Expenses (Quarterly) | 19.98M |
| Enterprise Value | 112.82M |
| Gross Profit Margin (Quarterly) | 78.03% |
| Profit Margin (Quarterly) | -12.18% |
| Earnings Yield | -4.36% |
| Normalized Earnings Yield | -4.361 |